Maynard Um
-
-
-
-
-
-
-
BofA Securities Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)
-
-
-
-
-
-
-
DATROWAY approved in US for first-line metastatic triple-negative breast cancer
-
-
-
-
-
-
-
AstraZeneca drug meets primary endpoint in rare disease trial
-
-
-
-
-
-
-
AstraZeneca's BREZTRI wins US approval for asthma treatment
-
-
-
-
-
-
-
AstraZeneca's IMFINZI and IMJUDO combination shows progression benefit in liver cancer
-
-
-
-
-
-
-
Advancements in Novel Immunotherapeutics in The Oncology Battle
-
-
-
-
-
-
-
AstraZeneca's CALQUENCE plus venetoclax wins FDA approval for CLL treatment
-
414,168 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

